HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

J A Montoya-Alonso Selected Research

Dirofilariasis

9/2022Evaluation of acute phase proteins, adiponectin and endothelin-1 to determine vascular damage in dogs with heartworm disease (Dirofilaria immitis), before and after adulticide treatment.
7/2020Evaluation of serum biomarkers and proteinuria for the early detection of renal damage in dogs with heartworm (Dirofilaria immitis).
11/2014Cardiopulmonary and inflammatory biomarkers in the assessment of the severity of canine dirofilariosis.
10/2013Utility of cardiac biomarkers during adulticide treatment of heartworm disease (Dirofilaria immitis) in dogs.
7/2013Variation of D-dimer values as assessment of pulmonary thromboembolism during adulticide treatment of heartworm disease in dogs.
1/2013D-dimer deposits in lungs and kidneys suggest its use as a marker in the clinical workup of dogs with heartworm (Dirofilaria immitis) disease.
10/2012Myocardial damage in dogs affected by heartworm disease (Dirofilaria immitis): immunohistochemical study of cardiac myoglobin and troponin I in naturally infected dogs.
3/2011Dirofilaria immitis infection in dogs: cardiopulmonary biomarker levels.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


J A Montoya-Alonso Research Topics

Disease

8Dirofilariasis
09/2022 - 03/2011
3Pulmonary Embolism
07/2013 - 03/2011
2Infections
01/2019 - 03/2011
2Thromboembolism
04/2015 - 11/2014
2Inflammation (Inflammations)
04/2015 - 11/2014
1Proteinuria
07/2020
1Lymphoma (Lymphomas)
01/2018
1Pneumonia (Pneumonitis)
04/2015
1Disseminated Intravascular Coagulation
11/2014
1Acute-Phase Reaction
08/2014
1Pathologic Processes
10/2013
1Myositis (Idiopathic Inflammatory Myopathies)
10/2013
1Thrombocytopenia (Thrombopenia)
07/2013
1Thrombosis (Thrombus)
01/2013
1Necrosis
10/2012
1Bites and Stings (Sting)
10/2010
1Heart Failure
06/2007
1Weight Loss (Weight Reduction)
05/2004

Drug/Important Bio-Agent (IBA)

4Biomarkers (Surrogate Marker)IBA
07/2020 - 03/2011
4fibrin fragment D (D-dimer)IBA
11/2014 - 03/2011
4MyoglobinIBA
11/2014 - 03/2011
3Troponin IIBA
11/2014 - 03/2011
2melarsomineIBA
04/2015 - 10/2013
2C-Reactive ProteinIBA
11/2014 - 08/2014
2Biological ProductsIBA
10/2013 - 03/2011
1Endothelin-1 (Endothelin 1)IBA
09/2022
1Acute-Phase Proteins (Acute-Phase Protein)IBA
09/2022
1AdiponectinIBA
09/2022
1AntibodiesIBA
01/2019
1SteroidsIBA
01/2018
1Doxycycline (Periostat)FDA LinkGeneric
04/2015
1pro-brain natriuretic peptide (1-76)IBA
11/2014
1Brain Natriuretic Peptide (Natrecor)FDA Link
11/2014
1AlbuminsIBA
08/2014
1HaptoglobinsIBA
08/2014
1Aryldialkylphosphatase (Paraoxonase)IBA
08/2014
1Fibrin Fibrinogen Degradation ProductsIBA
01/2013
1Proteins (Proteins, Gene)FDA Link
10/2012
1Troponin T (Troponin T1)IBA
03/2011
1ElectrolytesIBA
06/2007
1Torsemide (Demadex)FDA LinkGeneric
06/2007

Therapy/Procedure

2Drug Therapy (Chemotherapy)
01/2018 - 10/2010
1CHOP protocol (VDCP protocol)
01/2018
1Injections
01/2018
1Operative Surgical Procedures
01/2018
1Intramuscular Injections
10/2013
1Therapeutics
07/2013
1Diet Therapy (Therapy, Diet)
05/2004